Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment

Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment

<p>Secondary Antibody Information</p>

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Jonathan M.J. Derry (16648337) (author)
مؤلفون آخرون:	Connor Burns (16648340) (author), Jason P. Frazier (16648343) (author), Emily Beirne (16648346) (author), Marc Grenley (16648349) (author), Christopher C. DuFort (16648352) (author), Emily Killingbeck (16648355) (author), Michael Leon (16648358) (author), Claire Williams (16648361) (author), Mark Gregory (16648364) (author), Jeffrey Houlton (16648367) (author), Daniel Clayburgh (16648370) (author), Paul Swiecicki (16648373) (author), Dennis Huszar (16648376) (author), Allison Berger (15134507) (author), Richard A. Klinghoffer (16648379) (author)
منشور في:	2025
الموضوعات:	Cancer Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Immuno-oncology Methods and Technology Drug Discovery Technologies Novel assay technology Gene Regulation Posttranscriptional and translational control Head, Neck & Oral Cancers Immunology Immunomodulation Innate immunity Tumor-associated macrophages Translational Research Tumor Microenvironment Immune cells and the microenvironment
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
حسب: Jonathan M.J. Derry (16648337)
منشور في: (2025)

Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
حسب: Jonathan M.J. Derry (16648337)
منشور في: (2025)

Supplementary Table S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
حسب: Jonathan M.J. Derry (16648337)
منشور في: (2025)

Supplementary Table S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
حسب: Jonathan M.J. Derry (16648337)
منشور في: (2025)

Supplementary Table S6A from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
حسب: Jonathan M.J. Derry (16648337)
منشور في: (2025)

Supplementary Table S6B from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
حسب: Jonathan M.J. Derry (16648337)
منشور في: (2025)

Suppl video 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
حسب: Andrew O. Yam (15293045)
منشور في: (2025)

Suppl video 2 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
حسب: Andrew O. Yam (15293045)
منشور في: (2025)

Suppl video 3 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
حسب: Andrew O. Yam (15293045)
منشور في: (2025)

Suppl video 4 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
حسب: Andrew O. Yam (15293045)
منشور في: (2025)

Supplementary Table 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
حسب: Andrew O. Yam (15293045)
منشور في: (2025)

Table S9 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
حسب: Zhihang Chen (17315678)
منشور في: (2025)

Supplementary Table S1 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
حسب: Erika Y. Faraoni (14844897)
منشور في: (2025)

Supplementary Table S3 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
حسب: Erika Y. Faraoni (14844897)
منشور في: (2025)

Supplementary Table S4 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
حسب: Erika Y. Faraoni (14844897)
منشور في: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
حسب: Yu Chen (1234761)
منشور في: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
حسب: Yu Chen (1234761)
منشور في: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
حسب: Yu Chen (1234761)
منشور في: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
حسب: Yu Chen (1234761)
منشور في: (2025)

Supplemental Tables 1-8 from Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated <i>SPP1</i><sup>+</sup> Macrophages and Fibroblasts
حسب: Anuja Sathe (15028097)
منشور في: (2025)

Supplementary video from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
حسب: Min Wu (14962986)
منشور في: (2025)

Table S1 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
حسب: Min Wu (14962986)
منشور في: (2025)

Table S2 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
حسب: Min Wu (14962986)
منشور في: (2025)

Table S3 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
حسب: Min Wu (14962986)
منشور في: (2025)

Figure 1 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
حسب: Ernesto Gargiulo (15134961)
منشور في: (2025)

Figure 2 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
حسب: Ernesto Gargiulo (15134961)
منشور في: (2025)

Figure 3 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
حسب: Ernesto Gargiulo (15134961)
منشور في: (2025)

Figure 4 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
حسب: Ernesto Gargiulo (15134961)
منشور في: (2025)

Figure 5 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
حسب: Ernesto Gargiulo (15134961)
منشور في: (2025)

Figure 6 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
حسب: Ernesto Gargiulo (15134961)
منشور في: (2025)

Figure 7 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
حسب: Ernesto Gargiulo (15134961)
منشور في: (2025)

Supplementary Table S1 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
حسب: Ernesto Gargiulo (15134961)
منشور في: (2025)

Supplementary Table S2 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
حسب: Ernesto Gargiulo (15134961)
منشور في: (2025)

Supplementary Table S3 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
حسب: Ernesto Gargiulo (15134961)
منشور في: (2025)

Supplementary Table S4 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
حسب: Ernesto Gargiulo (15134961)
منشور في: (2025)

Table S1 from Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
حسب: Hanyun Zhang (15386757)
منشور في: (2025)

Table S2 from Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
حسب: Hanyun Zhang (15386757)
منشور في: (2025)

Supplementary Data from Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer
حسب: Kankan Cao (16437263)
منشور في: (2025)

Supplementary Figures SF1-SF9 from Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment
حسب: Robin M. Hallett (15037427)
منشور في: (2025)

Supplementary Tables ST1-ST6 from Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment
حسب: Robin M. Hallett (15037427)
منشور في: (2025)

Cannot write session to /tmp/vufind_sessions/sess_mt0347tfq238occa8rqt0ntgl9